This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.03% per year. These returns cover a period from January 1, 1988 through July 1, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
4 Blue-Chip Stocks to Win Big on Phase-One Trade Deal
by Nilanjan Banerjee
Wall Street rallied following the first phase of the U.S.-China trade pact, with Dow Jones Industrial Average and S&P 500 closing at record highs.
4 Must-Buy Dow Stocks Ahead of Earnings Reports This Month
by Nalak Das
The last three months of the year were quite promising for the Dow as the U.S.-China trade war finally seemed to ease.
Snap Up 5 Mega-Cap Stocks with Impressive Growth Prospects
by Nilanjan Choudhury
Mega-caps, usually the largest and most established companies in the stock market, tend to be stable, and many of them pay dividends based on their earnings.
5 ESG Stocks to Buy as Climate Risk Takes Center Stage
by Zacks Equity Research
Recent climatic catastrophes have led investors toward climate change-related investments. Here are five stocks that fit into the climate-risk portfolio.
Lamb Weston Looks Promising on LTO Focus & Solid Price/Mix
by Zacks Equity Research
Lamb Weston (LW) is focused on efficient price/mix, buyouts and capacity expansion efforts. Further, the company is gaining from its LTO innovation.
These Stocks Will Gain From a Boom is Health Technology
by Zacks Equity Research
The current demographic trend calls for development in technology associated to healthcare. Here are three stocks that can make the most from the health technology boom.
Procter & Gamble (PG) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
Procter & Gamble (PG) closed the most recent trading day at $124.88, moving +0.73% from the previous trading session.
What's in Store for Procter & Gamble (PG) in Q2 Earnings?
by Zacks Equity Research
Procter & Gamble's (PG) second-quarter fiscal 2020 results are likely to reflect gains from organic sales and growth initiatives. Adverse currency might have been a drag.
Colgate's (CL) Growth Initiatives On Track, Cost Woes Persist
by Zacks Equity Research
Colgate (CL) witnesses soft margins on increased raw material costs, higher SG&A expenses and currency woes. However, its innovation plans, savings program and expansion strategies might help.
McCormick (MKC) Looks Solid on Innovation & Saving Efforts
by Zacks Equity Research
McCormick (MKC) is on track with the CCI program to boost savings. Also, the company's focus on new product launches is augmenting its market share.
Helen of Troy (HELE) Q3 Earnings & Sales Rise Y/Y, Stock up
by Zacks Equity Research
Helen of Troy's (HELE) Q3 earnings and sales increase year over year on strength in the Housewares and Beauty segment. However, the Health & Home segment looks troubled.
Procter & Gamble's Billie Buyout to Boost Grooming Portfolio
by Zacks Equity Research
Procter & Gamble (PG) intends to buy Billie to further boost its women's care portfolio. This is likely to enhance its grooming business.
The Zacks Analyst Blog Highlights: Apple, NIKE, Procter & Gamble, Walmart and American Express
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Apple, NIKE, Procter & Gamble, Walmart and American Express
4 Factors That Make Pilgrim's Pride (PPC) an Attractive Pick
by Zacks Equity Research
Pilgrim's Pride (PPC) is gaining from robust Prepared Foods business. Also, focus on key customers and positive impacts from acquisitions bode well.
Procter & Gamble (PG) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
Procter & Gamble (PG) closed the most recent trading day at $122.01, moving -0.6% from the previous trading session.
TreeHouse Foods Down on Dismal Sales: Any Scope for Revival?
by Zacks Equity Research
TreeHouse Foods (THS) struggles with sluggish sales in its Baked and Meal Solutions units. Soft margins are also a concern.
Buy 5 Blue-Chip Stocks on Best Intra-Day Recovery in 3 Months
by Nalak Das
Wall Street's bull-run in 2019 halted on Jan 3 after the U.S. airstrikes in Iran killing its military general Qasem Soleimani. However, market recovered the next trading day on Jan 6.
Molson Coors to Shut Irwindale Facility, Offers Pabst to Buy
by Zacks Equity Research
Molson Coors (TAP) expects to stop production at its Irwindale, CA-based brewery by September 2020. The move is in sync with its efforts to revitalize and restructure its business.
Weak Volumes & Cost Hurt Molson Coors, Growth Efforts on Track
by Zacks Equity Research
Molson Coors (TAP) is grappling with weakness in volumes and high input cost. However, the company's solid brand portfolio, premiumization efforts and cost-saving initiatives bode well.
Will Tyson Foods' (TSN) Solid Momentum Continue This Year?
by Zacks Equity Research
Tyson Foods (TSN) is focusing on enriching portfolio and benefit from rising demand for protein-packed products. However, rising input costs are a concern.
Lamb Weston's (LW) Q2 Earnings Beat Estimates, Sales Rise Y/Y
by Zacks Equity Research
Lamb Weston's (LW) Q2 earnings and sales increase year over year, backed by improved volumes and price/mix across segments.
Energizer Concludes Sale of European Varta Battery Business
by Zacks Equity Research
Energizer (ENR) divests its Europe-based Varta battery business to Germany-based VARTA AG to comply with its previously agreed terms with the European Commission.
Will Kimberly-Clark's Impressive Momentum Continue in 2020?
by Zacks Equity Research
Kimberly-Clark's (KMB) focus on restructuring programs, product innovation and cost-saving plans bode well. However, the K-C Professional business looks troubled.
The Zacks Analyst Blog Highlights: Procter & Gamble, Enterprise Products, UBS, Cintas and OGE
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Procter & Gamble, Enterprise Products, UBS, Cintas and OGE
Why P&G (PG) Could Beat Earnings Estimates Again
by Zacks Equity Research
P&G (PG) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.